Taurus Meds TRT 2026: $49 Start, $149/mo - Platform Verification, Pricing, and What to Check Before You Pay

WILMINGTON, Del., April 14, 2026 (Newswire.com) - Disclaimer: This article is for informational purposes only and does not constitute medical advice. Testosterone replacement therapy is a prescription treatment that requires evaluation by a licensed healthcare provider. A commission may be earned if services are accessed through links in this article, at no additional cost to the reader. This compensation does not influence the accuracy or integrity of the information presented. TRT requires evaluation by a licensed clinician; a prescription is not guaranteed. Always consult a qualified healthcare professional before starting any prescription treatment or making changes to your health regimen.

Taurus Meds TRT 2026: Platform Structure, Pricing Details, and What to Verify Before Starting Online Testosterone Therapy

Men searching for testosterone replacement therapy in 2026 are doing their homework before they hand over their health history - or their credit card number. Platforms like Taurus Meds appear in a lot of ads, which naturally triggers a round of verification searches: Is Taurus Meds legitimate? Who is actually doing the prescribing? What does it cost in plain numbers? And what happens if the clinician decides TRT is not right for you?

This overview examines Taurus Meds using publicly available documentation - the company's terms of service, affiliated telehealth consent materials, and published pricing - so readers can evaluate the platform with a grounded understanding of how it operates and what questions to bring to a licensed healthcare provider. This is not a recommendation, and it does not replace a conversation with a clinician who knows your medical history.

View the current Taurus Meds offer (official Taurus Meds page)

What Taurus Meds Is - And What It Is Not

This distinction matters more than almost anything else in this article, and it is the aspect of telehealth TRT platforms most commonly misunderstood.

Taurus Medical, Inc. is a Delaware-registered company that operates taurusmeds.com as a technology platform. According to the company's published terms of service, Taurus Medical, Inc. is not itself a healthcare provider. The platform provides the digital infrastructure - patient intake, scheduling, provider communication, prescription routing - but it does not make clinical decisions and cannot issue prescriptions.

OpenLoop Healthcare Partners, PC is the affiliated medical group through which independent licensed clinicians evaluate patients and, where medically appropriate, issue prescriptions. These are state-licensed healthcare professionals - physicians, nurse practitioners, or physician assistants - who exercise independent medical judgment. The published telehealth consent form is explicit: completing the intake process does not guarantee a prescription. The evaluating clinician may determine that TRT is not appropriate based on lab values, health history, or other individual clinical factors.

Partner Pharmacies fulfill prescriptions issued by the licensed providers. According to documentation published at taurusmeds.com, pharmacy partners include RedRock Pharmacy (St. George, UT), Health Warehouse (Florence, KY), Precision Compounding Pharmacy (Bellmore, NY), and Triad Rx (Daphne, AL). These are licensed pharmacies that dispense medications based on individual prescriptions.

This three-entity structure - technology platform, licensed medical group, licensed pharmacy - is standard architecture for telehealth services operating in regulated categories. Understanding it sets accurate expectations before starting the intake process. For a broader look at how direct-to-consumer TRT telehealth services operate within current regulatory frameworks, a separate consumer analysis covering these structures in detail is available for reference.

Company Verification and Operational Structure

Readers searching terms like "Is Taurus Meds legit" are typically looking to verify a few specific things: Is the company real? Are the prescribers licensed? Are the pharmacies legitimate? Are the pricing terms honest? Here is what the documentation confirms on each point.

Company registration: According to the terms of service, Taurus Medical, Inc. is registered at 2810 North Church Street, PMB 371469, Wilmington, DE 19802. The company lists support@taurusmeds.com as its customer contact.

Medical group: The affiliated medical practice is OpenLoop Healthcare Partners, PC, headquartered at 317 6th Ave, Des Moines, IA 50309. OpenLoop operates as a multi-state medical group with affiliated PC entities in California, Colorado, New Jersey, Wisconsin, and Puerto Rico. The telehealth consent form is published under OpenLoop Healthcare Partners, PC, which carries responsibility for the clinical side of the service.

Pharmacy partners: All four pharmacy partners named in the terms of service are verifiable licensed pharmacies with published physical addresses and phone numbers. Readers can independently confirm pharmacy licensure through state pharmacy board records.

Pricing transparency: The official taurusmeds.com website publishes pricing directly. According to the site, the initial evaluation fee is $49, described as covering lab work through LabCorp or Quest Diagnostics and a clinician consultation. Ongoing medication costs, per the website, are $149 per month when purchasing six months upfront, or $199 per month on a standard month-to-month basis. Pricing is subject to change; always verify current terms on the official platform before purchasing.

Refund policy: According to the terms of service, all sales on shipped medications are final, and no refund will be issued. Blood work orders are also non-refundable, as those orders are submitted immediately upon payment to lab partners. Readers should review these terms directly before providing payment information.

View the current Taurus Meds offer (official Taurus Meds page)

The Step-by-Step Process: What the Documentation Describes

Based on publicly available information from taurusmeds.com and the affiliated telehealth consent materials, the Taurus Meds process follows a defined sequence.

Step 1 - Online health questionnaire: Prospective patients complete an intake covering medical history, current symptoms, medications, and health goals. This information is reviewed by the licensed clinical team prior to any testing or consultation.

Step 2 - Laboratory testing: The company states that laboratory testing is required before any treatment decision is made. Taurus partners with LabCorp and Quest Diagnostics, according to website documentation, allowing patients to complete testing at conveniently located collection sites. The $49 initial fee is described as covering this lab panel.

Step 3 - Clinician consultation: A licensed healthcare provider reviews the lab results and health intake to determine whether TRT, an alternative treatment, or in-person evaluation is the appropriate next step. The telehealth consent materials are explicit: completing the consultation does not guarantee a prescription. That determination rests entirely with the evaluating clinician based on individual health factors.

Step 4 - Prescription and delivery: If the evaluating clinician determines that treatment is appropriate, a prescription is issued and routed to a licensed partner pharmacy. The website describes free shipping for medication delivery.

Step 5 - Ongoing monitoring: Platform documentation describes ongoing provider access and periodic laboratory monitoring. Clinical guidelines generally call for regular monitoring of hormone levels, hematocrit, and other relevant markers during TRT; the specific schedule is determined by the prescribing clinician based on individual patient factors.

One important note from the consent materials: patients in some states may face restrictions on telehealth prescribing of controlled substances, including requirements for in-person visits. Telehealth TRT regulations vary by state. Individuals should confirm service availability in their state of residence before beginning the intake process. A full breakdown of the Taurus Meds online testosterone replacement process - covering consent documentation, lab requirements, and platform policies - is available for readers who want additional detail before proceeding.

Testosterone as a Controlled Substance: Regulatory and Clinical Context

Testosterone is classified as a Schedule III controlled substance under federal law. This classification has meaningful practical implications for anyone researching TRT - through telehealth or traditional in-person care.

Prescribing a Schedule III substance requires evaluation by an appropriately licensed provider. Telehealth prescribing of controlled substances is governed by both federal DEA rules and state-specific regulations, which have been under ongoing attention since pandemic-era flexibilities temporarily expanded telehealth prescribing authority. The regulatory environment continues to evolve, and service availability in specific states may shift.

FDA labeling updates for testosterone products - including class-wide safety considerations such as blood pressure-related warnings - reinforce the importance of clinician-guided evaluation and ongoing monitoring for anyone pursuing TRT. These safety considerations apply regardless of the prescribing channel.

This article does not constitute legal or regulatory advice. Individuals should discuss the specific requirements applicable to their situation with a licensed healthcare provider.

What Changed for Online TRT Prescriptions in 2026 - and What It Means Before You Start

The regulatory framework governing telehealth prescribing of controlled substances has been actively shifting since pandemic-era flexibilities that temporarily expanded remote prescribing authority began to expire. This matters directly to anyone researching online TRT access in 2026.

The DEA has issued guidance and proposed rulemaking affecting how Schedule III substances - including testosterone - can be prescribed via telehealth without a prior in-person evaluation. The framework has been extended in phases, but the direction of regulatory travel is toward tighter requirements in this space, not looser ones. Some telehealth platforms have adjusted their service models and geographic availability in response.

What this means practically before you start: Service availability through any telehealth TRT platform is subject to change based on both federal rulemaking and state-level decisions about telehealth prescribing authority. A platform that was available in your state last year may operate under different requirements today. Confirming current eligibility in your state of residence - directly with the platform, not through third-party content - is one of the most important verification steps a prospective patient can take before beginning the intake process.

This is genuine urgency, not manufactured scarcity. The rules governing this category have changed and continue to change. Readers who have been researching online TRT for a while should verify that current platform offerings align with what they initially researched, as program structures and availability can shift.

Compounded Medications: What the Documentation States

According to the platform's telehealth consent materials, some prescriptions may involve compounded medications depending on the clinician's determination and the pharmacy fulfillment pathway.

Compounded medications are not reviewed or approved by the FDA as finished products. This is stated explicitly in the OpenLoop telehealth consent materials attached to the Taurus platform and is consistent with standard FDA guidance on pharmaceutical compounding. Compounded preparations use active ingredients sourced from FDA-registered facilities, but the finished compounded product itself is not individually evaluated by the FDA for safety, effectiveness, or quality.

The decision between a compounded formulation and an FDA-approved generic testosterone product is a clinical determination made by the evaluating provider based on individual patient factors. Platform documentation indicates that Taurus services may facilitate access to both types, depending on clinical appropriateness. Only the prescribing clinician can determine which option, if any, is right for a given individual.

Patients who receive a prescription should review the medication information provided by their dispensing pharmacy and discuss any questions about formulation, handling, or monitoring directly with their prescribing clinician.

Treatment Options Referenced in Platform Documentation

Based on publicly available information, Taurus platform documentation references several treatment approaches. The clinical appropriateness of any specific option is determined solely by the evaluating provider.

Injectable testosterone is referenced in platform marketing materials as one of the available options and is among the most commonly discussed TRT delivery methods in clinical literature. The platform's website references different dosing frameworks, which reflect various clinical protocols. Specific protocol decisions are made entirely by the prescribing clinician.

Enclomiphene is referenced in platform documentation as an alternative for some patients, particularly those with fertility considerations for whom direct testosterone supplementation may not be the preferred clinical approach. Enclomiphene works through a different physiological mechanism than exogenous testosterone, stimulating the body's own hormone production pathway rather than replacing testosterone directly. Enclomiphene is a prescription medication and, like all hormone-related treatments, requires evaluation and ongoing monitoring by a licensed healthcare provider. Whether a patient is a candidate for enclomiphene is a clinical determination made by the evaluating provider.

What Clinical Research Says About Testosterone Therapy

This section summarizes published research findings on TRT in men with confirmed low testosterone. These are population-level findings from controlled clinical settings. They do not describe what any individual will experience, and they are not a substitute for a personalized evaluation by a licensed clinician.

A large-scale cardiovascular outcomes trial - the TRAVERSE study, published in The New England Journal of Medicine - examined TRT in men with hypogonadism and preexisting cardiovascular disease or risk factors. The trial found that testosterone therapy was noninferior to placebo with respect to major adverse cardiac events over a mean follow-up period of approximately 22 months. The testosterone group also showed a lower incidence of new-onset type 2 diabetes. These findings apply to the specific trial population and conditions; individual cardiovascular and metabolic risk must be assessed by a treating clinician.

According to systematic reviews of TRT in men with confirmed hypogonadism, potential associations have been reported with improvements in lean body mass, reductions in fat mass, and improvements in sexual function including libido. These represent aggregate findings from study populations with laboratory-confirmed low testosterone levels under monitored conditions. Individual results vary, are not guaranteed, and depend on numerous patient-specific factors including baseline hormone levels, age, overall health, and treatment consistency.

FDA labeling for testosterone products includes safety information on cardiovascular risk, polycythemia, and other potential effects. These labeling considerations apply to all testosterone preparations, including those prescribed through telehealth platforms. Clinician-guided evaluation and ongoing laboratory monitoring are standard components of responsible TRT management, regardless of the prescribing channel.

This research context is provided to support informed conversations with healthcare providers. It is not an endorsement of TRT as appropriate for any individual and does not constitute medical advice.

How Taurus Meds Compares to Other TRT Access Models

This section is not a recommendation and does not determine eligibility. Only a licensed healthcare provider can assess what approach is clinically appropriate for any individual. The following is a neutral overview of how different TRT access models differ structurally.

Telehealth TRT platforms (including Taurus Meds) vs. traditional in-person care: Telehealth platforms facilitate evaluation and prescription management online, without requiring in-person visits for the initial consultation or follow-up in most states. Traditional pathways - primary care, urology, endocrinology - involve in-person physical examination and may allow more comprehensive assessment of complex medical histories. Insurance coverage is more commonly available through traditional clinical pathways. Telehealth platforms typically do not accept insurance, though some HSA and FSA plans may reimburse qualifying prescription expenses depending on plan rules.

Prescription TRT vs. over-the-counter testosterone boosters: These are categorically different products. Prescription TRT - whether through telehealth or in-person care - involves actual testosterone, prescribed after laboratory confirmation of low levels, dispensed by a licensed pharmacy, and subject to ongoing clinical monitoring. Over-the-counter testosterone boosters are dietary supplements that do not contain testosterone and are not evaluated by the FDA for efficacy. They are not subject to the same regulatory framework as prescription medications.

Compounded testosterone vs. FDA-approved testosterone products: FDA-approved testosterone medications have been evaluated by the FDA for safety, effectiveness, and quality as finished products. Compounded formulations use active ingredients from FDA-registered sources but are not themselves FDA-approved finished products, as noted above. Both may be clinically appropriate depending on individual patient factors; that determination belongs to the prescribing provider.

Telehealth monitoring vs. in-person monitoring: Both prescription TRT channels require ongoing laboratory monitoring. Telehealth monitoring relies on remote lab draws through partner networks such as LabCorp and Quest, with results reviewed remotely by the prescribing clinician. In-person monitoring occurs at the provider's clinic or a referred lab, with the clinician available for direct examination during follow-up visits. Neither model eliminates the need for monitoring; the channel differs, not the requirement.

Pricing and Subscription Terms: What the Website States

The Taurus Meds website publishes pricing information directly, which supports pre-engagement transparency. All figures below reflect website documentation at the time of publication; verify current terms before purchasing.

According to the official site, the initial evaluation fee is $49, described as including lab work through LabCorp or Quest Diagnostics and a clinician consultation. Medication costs, per the website, are $149 per month when purchasing six months upfront, or $199 per month on a standard month-to-month basis. The site describes these as all-inclusive with no hidden fees.

Regarding cancellations: per the terms of service, subscriptions continue and auto-renew unless cancelled. Cancellation requests should be directed to support@taurusmeds.com and take effect at the end of the current paid term. Refunds on shipped medications are not offered under the published refund policy. Blood work fees are also non-refundable once submitted to lab partners.

Insurance coverage for direct-to-consumer telehealth TRT programs varies by plan. Many direct-to-consumer prescription programs are not covered by traditional insurance, but coverage policies differ. Readers should confirm benefits with their insurer. Some HSA and FSA plans may reimburse qualifying prescription expenses; individual plan rules apply. For readers who want a deeper walkthrough of Taurus Meds pricing, the intake process, and how to get started, a dedicated guide covering those specifics is also available.

View the current Taurus Meds offer (official Taurus Meds page)

Who Telehealth TRT Access May Align With

This section is not a recommendation and does not determine eligibility. Only a licensed healthcare provider can assess clinical appropriateness for any individual. The following reflects the service structure described in platform documentation and general considerations that may be relevant to different circumstances.

Telehealth TRT Access May Align With People Who:

Have not yet had testosterone levels formally evaluated and want a structured, lab-first pathway: The Taurus process includes laboratory testing as part of the initial fee, which provides clinically relevant data - actual testosterone levels - before any treatment decision is made. For individuals who have been experiencing symptoms but have not confirmed low testosterone through blood work, this may represent an accessible starting point for evaluation.

Live in areas with limited access to men's health or endocrinology specialists: Telehealth extends geographic reach for initial evaluation and ongoing monitoring, subject to state-specific telehealth regulations and clinical appropriateness at the individual level.

Prefer a consolidated digital workflow: The platform coordinates intake, scheduling, provider communication, and prescription routing through a single digital interface, which may suit individuals who prefer managing their healthcare digitally without coordinating between multiple offices.

Want pricing transparency before committing: Published pricing allows individuals to understand cost structure in advance. This may be useful for those without insurance coverage or those comparing telehealth costs with traditional care out-of-pocket expenses.

Traditional In-Person Care Pathways May Be Preferable For People Who:

Have complex medical histories or significant comorbidities: Individuals with conditions requiring hands-on physical examination, complex medication interactions, or substantial comorbidities may benefit from specialist evaluation in person.

Have active insurance coverage for hormone therapy evaluation: Those with coverage for endocrinology or men's health services through a traditional insurance plan may find in-person care more cost-effective than direct-pay telehealth.

Reside in states with in-person visit requirements for controlled substance prescribing: Telehealth TRT availability varies by state. Some states require in-person evaluation before a telehealth prescription for a Schedule III substance can be issued.

Prefer face-to-face clinical relationships and hands-on monitoring: Some individuals value the continuity and direct assessment available through an ongoing relationship with a consistent in-person provider.

Questions Worth Considering Before Starting Any TRT Evaluation:

• Have I confirmed low testosterone through laboratory testing, or am I relying on symptoms alone?

• Do I understand that a prescription is not guaranteed through this or any telehealth platform?

• Have I discussed TRT with my primary care physician?

• Am I prepared for the ongoing monitoring and follow-up that TRT requires?

• Have I read the refund and cancellation terms before providing payment information?

• Have I confirmed that telehealth TRT services are currently available in my state of residence?

Frequently Asked Questions

Is Taurus Meds a legitimate company?

Taurus Medical, Inc. is a Delaware-registered company with a published business address and contact email. Clinical services are facilitated through OpenLoop Healthcare Partners, PC, a verifiable multi-state medical group. Pharmacy partners are licensed pharmacies with published physical addresses. Readers can independently verify company registration, medical group licensure, and pharmacy standing through relevant state and federal licensing records. Reviewing all terms of service and consent materials directly on the official platform before engaging is always advisable.

Does Taurus Meds prescribe testosterone directly?

No. According to the company's published terms of service, Taurus Medical, Inc. is not a healthcare provider. Prescriptions are issued by independent licensed clinicians through OpenLoop Healthcare Partners, PC, based on individual evaluation. A prescription is not guaranteed, and the clinical decision rests entirely with the evaluating provider.

What is the actual cost of the Taurus Meds program?

According to the official website at the time of publication, the initial evaluation fee is $49 - described as covering lab work and a clinician consultation. Ongoing medication costs are $149 per month when purchasing six months upfront, or $199 per month on a month-to-month basis. All pricing is subject to change; verify current terms directly on the official platform before purchasing.

Are the medications compounded or FDA-approved?

According to the platform's telehealth consent materials, some prescriptions may involve compounded medications depending on the clinician's determination and the pharmacy fulfillment pathway. Compounded medications are not reviewed or approved by the FDA as finished products. FDA-approved generic testosterone options may also be available where clinically appropriate. The prescribing clinician determines which option is appropriate based on individual health factors.

What happens if the clinician determines TRT is not appropriate for me?

According to the telehealth consent documentation, the evaluating clinician may determine that TRT is not appropriate and may recommend alternative treatments or in-person evaluation. The refund policy states that lab work fees are non-refundable, as orders are submitted immediately upon payment. Readers should review refund terms directly before proceeding.

Is telehealth TRT available in all states?

Telehealth prescribing of controlled substances is subject to state-specific regulations that vary and continue to evolve. Some states impose additional requirements, including in-person visit rules. Service availability in a specific state of residence should be confirmed with the platform directly before beginning the intake process.

What did the DEA changes mean for online TRT in 2026?

Following the expiration of pandemic-era telehealth flexibilities, the DEA has been refining rules governing how controlled substances - including testosterone - can be prescribed via telehealth without a prior in-person visit. These rules have been extended in phases and continue to evolve. The practical implication for prospective patients is that platform availability and service terms may have changed since their last research. Always confirm current eligibility and service availability directly with the platform before starting the intake process.

What is enclomiphene and why might it be offered instead of testosterone?

Enclomiphene is a prescription medication that works through a different mechanism than direct testosterone supplementation - it stimulates the body's natural hormone production pathway rather than replacing testosterone externally. Platform documentation indicates it may be considered for some patients, particularly those with fertility considerations. Whether enclomiphene is appropriate for any individual is a clinical determination made by the evaluating provider. Like all hormone-related treatments, it requires evaluation and ongoing monitoring by a licensed healthcare professional.

What is the difference between TRT and over-the-counter testosterone supplements?

These are categorically different. Prescription TRT involves actual testosterone - a Schedule III controlled substance - dispensed by a licensed pharmacy following laboratory confirmation of low levels and evaluation by a licensed clinician. Over-the-counter testosterone supplements are dietary supplements that do not contain testosterone and are not subject to the same regulatory framework as prescription medications.

5 Things to Verify Before Starting the Taurus Meds Intake

Informed engagement with any prescription telehealth service starts with direct verification - not relying on third-party overviews, including this one. Before proceeding with Taurus Meds or any telehealth TRT platform, working through the following steps reduces surprises after you have already paid.

1. Read the current terms of service and refund policy in full. All sales on shipped medications are final under the published policy. Lab work fees are non-refundable once submitted. Knowing this before you pay - not after - is the difference between an informed decision and a frustrating one.

2. Read the telehealth consent materials before clicking "I agree." The OpenLoop consent form covers AI use in consultations, prescription non-guarantees, compounding disclosures, and state-specific patient rights. It runs long for a reason. The sections on what you are and are not guaranteed are particularly worth reading slowly.

3. Confirm current service availability in your specific state. Telehealth TRT availability varies by state and has been changing. Contact the platform directly or review its current eligibility disclosures - do not assume availability based on older research or advertising you saw months ago.

4. Check whether your HSA or FSA covers qualifying expenses. Many direct-to-consumer telehealth TRT programs are not covered by traditional insurance. However, some HSA and FSA plans do reimburse qualifying prescription expenses. A five-minute call to your plan administrator before starting may be worth meaningful dollars.

5. Discuss your interest in TRT with your primary care physician first. Your existing provider has access to your full medical history, current medications, and baseline labs in a way that a new telehealth intake form cannot replicate. A brief conversation with your primary care physician before starting can clarify whether telehealth evaluation is an appropriate fit for your specific situation - and may surface relevant context that changes your approach.

View the current Taurus Meds offer (official Taurus Meds page)

Regulatory Landscape: What to Know Before Proceeding

Telehealth prescribing of controlled substances, including testosterone, has been under sustained regulatory attention. DEA rules around telehealth prescribing of controlled substances evolved significantly following the pandemic-era flexibility that temporarily expanded remote prescribing authority, and that framework continues to be refined. Additional changes remain possible.

Readers should review the most current information about any platform's regulatory standing, service availability in their state, and compliance status before proceeding. This analysis reflects publicly available documentation as of April 2026. The regulatory environment and platform-specific terms may have changed since publication.

Contact Information

According to the company's published terms of service, Taurus Medical, Inc. can be reached at:

Email: support@taurusmeds.com
Mailing address: 2810 North Church Street, PMB 371469, Wilmington, DE 19802

For current program details, pricing, and eligibility information, contact the platform directly or visit the official website.

View the current Taurus Meds offer (official Taurus Meds page)

Disclaimers

Affiliate Disclosure: This article contains affiliate links. If services are accessed through these links, a commission may be earned at no additional cost to the reader. This compensation does not influence the accuracy, neutrality, or integrity of the information presented. All descriptions are based on publicly available platform documentation.

Medical Disclaimer: This article is for informational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Testosterone replacement therapy is a prescription treatment requiring evaluation by a licensed healthcare provider. Do not start, stop, or change any treatment without consulting a qualified healthcare professional. Individual health factors determine clinical appropriateness; a prescription is not guaranteed through any telehealth platform. Consult your physician before making any changes to your health regimen, especially if you take other medications or have existing health conditions.

Telehealth Platform Notice: According to its published terms of service, Taurus Medical, Inc. operates as a technology platform and is not itself a healthcare provider. Medical evaluation and prescribing decisions are made by independent licensed clinicians through OpenLoop Healthcare Partners, PC. Taurus Medical, Inc. does not make clinical decisions and cannot guarantee that any individual will receive a prescription.

Compounded Medication Notice: According to the platform's telehealth consent materials, some patients may receive compounded medications prepared by licensed pharmacies based on an individual prescription. Consistent with FDA guidance, compounded medications are not reviewed or approved by the FDA as finished products. They are prepared using active ingredients from regulated sources under the direction of a prescribing clinician.

Clinical Research Context: Research findings referenced in this article reflect published clinical studies and systematic reviews conducted in specific populations under controlled conditions. Individual results vary and are not guaranteed. Clinical findings do not constitute a representation that any individual will experience similar outcomes.

Results May Vary: Individual outcomes vary based on factors including baseline testosterone levels, age, overall health status, treatment consistency, monitoring compliance, and other individual variables. Results are not guaranteed. The platform's own consent documentation states that no specific results can be assured.

Pricing Disclaimer: All pricing information reflects publicly available website documentation at the time of publication (April 2026) and is subject to change without notice. Always verify current pricing, subscription terms, and refund policies directly on the official Taurus Meds website before purchasing.

Regulatory Notice: Telehealth prescribing of controlled substances including testosterone is subject to federal and state regulations that continue to evolve. Service availability varies by state. Readers should verify current regulatory requirements and service availability in their state of residence before proceeding.

Publisher Responsibility Disclaimer: The publisher has made every effort to ensure accuracy at the time of publication based on publicly available documentation. The publisher does not accept responsibility for errors, omissions, or outcomes resulting from the use of information provided. Readers are encouraged to verify all details directly with Taurus Meds and their healthcare provider before making decisions.

SOURCE: Taurus

Source: Taurus